FundedIQ
Biotechnology

Ammortal: Funding, Investors & Team (Sep 2026)

Ammortal is a healthcare services company that offers bio-optimization services.

www.ammortal.com LinkedIn Mars Hill, United States 11-50 employees
Total raised
$25.0M
Rounds
1
Latest
Undisclosed round
Mar 2026

Ammortal has raised $25.0M across 1 funding round on record, the most recent an undisclosed round of $25.0M announced in Mar 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Ammortal Company Profile and Key Stats

Total funding raised
$25.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$25.0M in Mar 2026
Employees
11-50
reported band
Headquarters
Mars Hill, United States

Latest funding round on record: Mar 2026.

Ammortal Funding Rounds

Date
Round
Amount
Undisclosed round
$25.0M

Ammortal Founders and Leadership Team

Name
Role
Contact
Brian Le Gette
Founder
Locked

Contact details for the Ammortal team: 1 has a LinkedIn profile.

Start 14-day free trial →

Ammortal Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M

Ammortal's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Ammortal in Biotechnology and Mars Hill

Companies Similar to Ammortal

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Ammortal Funding FAQs

What does Ammortal do?

Ammortal is a healthcare services company that offers bio-optimization services.

How much funding has Ammortal raised?

Ammortal has raised $25.0M across 1 round on record. The most recent is an undisclosed round of $25.0M announced in Mar 2026.

When did Ammortal last raise funding?

Ammortal's most recent funding round on record is an undisclosed round of $25.0M, announced in Mar 2026.

Who founded Ammortal?

FundedIQ lists Brian Le Gette (Founder) at Ammortal.

Where is Ammortal headquartered?

Ammortal is based in Mars Hill, North Carolina, United States.

How many employees does Ammortal have?

Ammortal is in the 11-50 employee band.

How does Ammortal's funding compare to other Biotechnology startups?

Ammortal's latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's Ammortal Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ammortal is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.